Natural Biocon Intrinsic Value

NATURAL • Chemicals
Current Stock Price
₹4.29
Primary Intrinsic Value
₹10.72
Market Cap
₹11.2 Cr
+149.9% Upside
Median Value
₹10.72
Value Range
₹1 - ₹11
Assessment
Trading Below Calculated Value
Safety Margin
60.0%

NATURAL Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹10.72 ₹9.65 - ₹11.79 +149.9% Book Value/Share: ₹12.31, P/B: 1.0x
Revenue Multiple Method revenue ₹1.29 ₹1.16 - ₹1.42 -69.9% Revenue/Share: ₹1.54, P/S: 0.8x
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check NATURAL share price latest .

Valuation Comparison Chart

NATURAL Intrinsic Value Analysis

What is the intrinsic value of NATURAL?

Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Natural Biocon (NATURAL) is ₹10.72 (median value). With the current market price of ₹4.29, this represents a +149.9% variance from our estimated fair value.

The valuation range spans from ₹1.29 to ₹10.72, indicating ₹1.29 - ₹10.72.

Is NATURAL undervalued or overvalued?

Based on our multi-method analysis, Natural Biocon (NATURAL) appears to be trading below calculated value by approximately 149.9%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Debt to Equity Ratio 1.22 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Operating Margin -2.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.10x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹1 Cr ₹-10 Cr Positive Operating Cash Flow 6/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2021 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10